Study of EXPAREL in Patients Undergoing Breast Augmentation

Inclusion Criteria: * Female, 18-75 years of age inclusive. * American Society of Anesthesiologists (ASA) physical status 1-3. * Undergoing bilateral augmentation mammoplasty without any concurrent surgical procedure(s). * Physically and mentally able to participate in the study and complete all study assessments. * Able to give fully informed consent to participate in this study after demonstrating a good understanding of the risks and benefits of the study components. Exclusion Criteria: * History of hypersensitivity or idiosyncratic reactions to amide-type local anesthetics. * Any subject whose anatomy or surgical procedure might, in the opinion of the Investigator, preclude the potential successful local administration of EXPAREL. * Subjects currently pregnant or who may become pregnant during the course of the study. * Any subject who in the opinion of the Investigator might be harmed or be a poor candidate for participation in the study. * Subjects who have received any investigational drug within 30 days prior to study drug administration, or planned administration of another investigational product or procedure during their participation in this study.